[HTML][HTML] SARS-CoV-2 infection: a possible risk factor for incidence and recurrence of cancers

A Jafarzadeh, R Gosain, SMJ Mortazavi… - … -Oncology and Stem …, 2022 - ncbi.nlm.nih.gov
SARS-CoV-2-infected cancerous patients are unable to produce an effective anti-virus …
of SARS-CoV-2 infection on cancer development and recurrence, and the potential cancer

SARS-CoV-2 infection and high-risk non-muscle-invasive bladder cancer: are there any common features?

GM Busetto, A Porreca, F Del Giudice, M Maggi… - Urologia …, 2020 - karger.com
… Tobacco smoking is considered a risk factor for bladder cancer recurrence and
progression. Smoking pattern, intensity and duration are responsible for poorer bladder …

Remission of liquid tumors and SARS-CoV-2 infection: A literature review

DH Shin, A Gillard, A Van Wieren… - Molecular Therapy …, 2022 - cell.com
… acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that resulted in cancer remission,
… A phase I study was conducted on 61 patients with recurrent malignant gliomas based on …

Gynecologic cancer surveillance in the era of SARS-CoV-2 (COVID-19)

G Mancebo, JM Solé-Sedeño, I Membrive… - … of Gynecologic Cancer, 2021 - ijgc.bmj.com
… . A national, prospective observational study of first recurrence after primary treatment for
gynecological cancer in Norway. Acta Obstet Gynecol Scand 2017;96:1162–9.doi:10.1111/aogs…

Infection and reinfection with SARS-CoV-2 in cancer patients: a cohort study

C Nitipir, AI Parosanu, M Olaru… - Experimental and …, 2022 - spandidos-publications.com
… in cancer patients with … cancers, pulmonary cancer patients had a particularly higher overall
mortality rate (6). Although the term reinfection is somewhat controversial, the recurrence of …

[HTML][HTML] Correlation of SARSCoV‑2 to cancer: Carcinogenic or anticancer?

YS Li, HC Ren, JH Cao - International journal of …, 2022 - spandidos-publications.com
… (NK cell) lymphoma and Hodgkin's lymphoma, while SARSCoV‑2 elicited anti‑tumor immune
… characteristics of SARSCoV‑2 as well as strategies to protect patients with cancer during …

[HTML][HTML] Commentary: SARS-CoV-2 vaccines and cancer patients

C Corti, G Curigliano - Annals of Oncology, 2021 - ncbi.nlm.nih.gov
… of coronavirus disease 2019 (COVID-19), severe acute respiratory syndrome coronavirus 2
(SARS-Cov-2) … 1 Higher mortality of COVID-19 seems to be related to cancer, but data are …

[HTML][HTML] Cancer patients in SARS-CoV-2 infection: a single-center experience from Wuhan

J Wang, J Zhang, Y Tu, X Zhou, H Huang… - … of Cancer, 2020 - ncbi.nlm.nih.gov
… Conclusion: Cancer is a … cancer patients should be addressed during COVID-19 pandemic,
along with meticulous personal protective protocols for them to mitigate the risk of SARS-CoV

[HTML][HTML] SARSCoV‐2 reinfection in a cancer patient with a defective neutralizing humoral response

C Borgogna, M De Andrea, G Griffante… - Journal of medical …, 2021 - ncbi.nlm.nih.gov
SARSCoV‐2 infection. In the next few months, the patient did not show any respiratory
symptoms. However, the deterioration of his cancer … , causing concern for a recurrence of COVID‐…

A systematic review on the recurrence of SARS-CoV-2 virus: frequency, risk factors, and possible explanations

SM Piri, M Edalatfar, S Shool, MN Jalalian… - Infectious …, 2021 - Taylor & Francis
… review to evaluate rate of SARS-CoV-2 recurrence, changes in disease … SARS-CoV-2 and
disease recurrence, disease and patients’ characteristics, risk factors for predicting recurrence